The pharma commercialization landscape is evolving at an unprecedented speed. At Frontiers Health 2025, our team joined industry leaders to discuss how global launches, pricing strategies and patient access are being reshaped by policy changes and innovation.
Alan Crowther and Mike Ryan were onstage focusing on:
- Policy Shifts: How Most Favored Nations pricing is influencing global access.
- Innovation Meets Adoption: Why aligning breakthrough therapies with payer expectations is critical.
- Holistic Value Propositions: Building strategies that resonate with payers, clinicians, and patients.
- Accelerating Time-to-Market: Practical approaches to navigate complexity and deliver faster.
Watch the full interview by pharmaphorum for actionable insights from EVERSANA’s Alan Crowther and Mike Ryan, alongside MENARINI Group and SpringWorks Therapeutics.
Learn more about EVERSANA’s commercialization solutions.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…